Cargando…
Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series
BACKGROUND: Clozapine has a unique efficacy profile among individuals suffering from treatment-resistant schizophrenia, but is associated with hematological side effects. The use of granulocyte colony-stimulating factors (G-CSF) to allow clozapine continuation or rechallenge has emerged as a promisi...
Autores principales: | Béchard, Laurent, Corbeil, Olivier, Plante, Maude, Thivierge, Marc-André, Lafrenière, Charles-Émile, Roy, Marc-André, Demers, Marie-France |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436292/ https://www.ncbi.nlm.nih.gov/pubmed/34229529 http://dx.doi.org/10.1177/02698811211029737 |
Ejemplares similares
-
S1. CLOZAPINE RECHALLENGE FOLLOWING NEUTROPENIA USING GRANULOCYTE COLONY-STIMULATING FACTOR: A QUEBEC CASE SERIES
por: Béchard, Laurent, et al.
Publicado: (2020) -
Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review
por: Corbeil, Olivier, et al.
Publicado: (2023) -
Management of Rhabdomyolysis in a Patient Treated with Clozapine: A Case Report and Clinical Recommendations
por: Béchard, Laurent, et al.
Publicado: (2022) -
Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide
por: Silva, Edward, et al.
Publicado: (2020) -
Successful clozapine rechallenge after neutropenia using lithium carbonate : a case report
por: Khattech, D., et al.
Publicado: (2022)